Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges OWLT Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Despite Stock Decline Passage Bio Q1 2026 Earnings Narrowerthanexpected loss signals disciplined spending RYTM Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction AQST Q1 2026 Earnings Narrower Loss Beats Estimates as Company Progresses Pipeline